Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 12/2007

01-12-2007 | Case Report

Colchicine-induced rhabdomyolysis

Authors: Arie Altman, Martine Szyper-Kravitz, Yehuda Shoenfeld

Published in: Clinical Rheumatology | Issue 12/2007

Login to get access

Abstract

A case of colchicine-induced rhabdomyolysis is reported. A 79-year-old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of fatigue, myalgia, and leg weakness, shortly after starting treatment with colchicine. Investigation confirmed the diagnosis of rhabdomyolysis, and discontinuation of colchicine resulted in resolution of clinical and biochemical features of rhabdomylysis. Colchicine-induced rhabdomyolysis is a rare complication, and the postulated mechanisms and risk factors for this severe complication are discussed.
Literature
1.
Insel PA (1996) Analgesic–antipyretic and anti inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, Molineff PB et al (eds) The pharmacological basis of therapeutics. Mcgraw-Hill, New York, pp 647–649
2.
Wilbur F, Makowsky M (2004) Colchicine myotoxicity: case reports and literature review. Pharmacotherapy 24:1784–1792CrossRefPubMed
3.
Dawson TM, Starkebaum G (1997) Colchicine induced rhabdomyolysis. J Rheumatol 24:2045–2046PubMed
4.
Del Favero A (1981) Anti-inflammatory analgesics and drugs used in rheumatism and gout. In: Dukes MNG (ed) Side effects of drugs. Excerpta Medica, New York, p 109
5.
Chattopaahyay I, Sherry HGM, Routledge PA, Jeffery J (2001) Colchicine induced rhabdomyolysis. Postgrad Med J 77:191–192CrossRef
6.
Wallace SL, Singer JZ, Duncan GJ, Wigley FM, Kuncl RW (1991) Renal function predicts colchicines toxicity: guidelines for the prophylactic use of colchicines in gout. J Rheumatol 18:264–269PubMed
7.
Younger DS, Mayer SA, Weimer LH, Alderson LM, Seplowitz AH, Lovelace RE (1991) Colchicine myopathy and neuropathy. Neurology 41:943CrossRefPubMed
8.
Rieger EH, Halasz NA, Wahlstrom LM (1990) Colchicine neuromyopathy after renal transplantation. Transplantation 49:1196–1198CrossRefPubMed
9.
Kontos HA (1962) Myopathy associated with chronic colchicines toxicity. N Eng J Med 266:38–39CrossRef
10.
Kuncl RW, Ducan G, Watson D et al (1987) Colchicine myopathy and neuropathy. N Eng J Med 316:1562–1568CrossRef
11.
Rriggs JE, Schocher SS Jr, Gutmann L, Crosby TW, DiBartolomeo AG (1986) Chronic human colchicine neuropathy and myopathy. Arch Neurol 43:521–523CrossRef
12.
Adler Y, Finkelstein Y, Guindo J et al (1998) Colchicine treatment for recurrent pericarditis: a decade of experience. Circulation 97:2183–2185CrossRefPubMed
13.
14.
Lange U, Schumann C, Schmidt KL (2001) Current aspects of colchicines therapy: classical indications and new therapeutic uses. Eur J Med Res 6:150–160PubMed
15.
Naidus RM, Rodvein R, Mielke CH Jr (1997) Colchicine toxicity: a multisystem disease. Arch Intern Med 137:394–396CrossRef
Metadata
Title
Colchicine-induced rhabdomyolysis
Authors
Arie Altman
Martine Szyper-Kravitz
Yehuda Shoenfeld
Publication date
01-12-2007
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0682-2

Other articles of this Issue 12/2007

Clinical Rheumatology 12/2007 Go to the issue

Case Report

Major flares in women with SLE on combined oral contraception

Case Report

Behçet’s disease and Chiari’s network

Original Article

The Fibromyalgia Bladder Index

Case Report

Pericarditis: a rare complication of methotrexate therapy

Original Article

Socioeconomic impact of ankylosing spondylitis in Morocco

Original Article

Synovial proliferation differentially affects hypoxia in the joint cavities of rheumatoid arthritis and osteoarthritis patients

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits